Arkolith/Insider Trading/AXSM/Form 4

Tabuteau Herriot

Chief Executive Officer, Director, 10% OwnerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jan 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23.9M
Net Open-Market Flow
-$23.9M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)31K$8.02$251K38K
Jan 7, 2026Sell(S)31K$170.38$5.3M7K
Jan 6, 2026Option exercise(M)29K$8.02$236K37K
Jan 6, 2026Sell(S)29K$172.33$5.1M7K
Jan 5, 2026Option exercise(M)79K$8.02$631K86K
Jan 5, 2026Sell(S)79K$171.28$13.5M7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 7, 2026Option exercise(M)31K—$032K
Jan 6, 2026Option exercise(M)29K—$064K
Jan 5, 2026Option exercise(M)79K—$093K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-006695) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML